argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 610.40
+4.40 (0.73%)
Sep 3, 2025, 5:36 PM CET
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
€1,661,901
Profits / Employee
€681,838
Market Cap
37.09B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 150 | 80.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,378 |
| Fagron NV | 3,828 |
| Ion Beam Applications | 2,287 |
| Onward Medical | 103 |
| Nyxoah | 184 |
| Hyloris Pharmaceuticals | 49 |
| Sequana Medical NV | 48 |
| European Medical Solutions | 122 |
argenx SE News
- 1 day ago - B of A Securities Raises Price Target on ARGX to $887 | ARGX Stock News - GuruFocus
- 6 days ago - argenx to Present at Upcoming Investor Conferences - GlobeNewsWire
- 8 days ago - Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded - Investor's Business Daily
- 8 days ago - Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win - Benzinga
- 8 days ago - Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win - Benzinga
- 9 days ago - Argenx Tops Buy Point On Bullish Study, 850 Price Target - Investor's Business Daily
- 9 days ago - Argenx Targets FDA Label Expansion After Vyvgart Trial Success - Benzinga
- 9 days ago - argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG - GlobeNewsWire